MPM Oncology Innovations FUND L.P., 10% Owner at Aktis Oncology, Inc. (AKTS), bought 2,689,896 shares at $18.00 ($20.0M) on 2026-01-12, disclosed to the SEC on 2026-01-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,577,119 | $0 | 0.0% |
| 2 | $18.00 | 1,112,777 | $20.0M | 100.0% |
| Total | $7.45 avg | 2,689,896 | $20.0M | 100% |